The practice of medicine in fraught with moral and philosophical conundrums. The more complex and dramatic the medical intervention, the deeper the questions connected to such activities. Questions that have been in the public eye range from the debate over the right to refuse vaccines or other medical treatments because of religious belief to questions regarding both end of life and beginning of life decisions.
In veterinary medicine, many (though not all) of the moral dilemmas faced by people doctors are also confronted. One area where veterinary medicine appears to have had less trouble than human medicine is in the area of end of life decisions. As animals cannot express their desires, we seem to have developed a greater degree of comfort with understanding that at times the best path for an animal is to be released from suffering through euthanasia.
This decision is not as simple as it once was, however, given advances in medicine, especially the contributions made using 3D printing technologies. According to the UK’s supervet Professor Noel Fitzpatrick, it is increasingly possible to save an animal’s life in circumstances that just a few short years ago would have been seen as necessarily terminal. Given these expanded possibilities, the question that now arises is: when should an animal’s life be saved and when should it not?
Like all complex issues, there is an emotional element to this decision that not only makes it more difficult, but also provides the only possible mechanism by which an answer can be reached. Now that so much can be accomplished the question is no longer one of possibility but rather of what is right.
At what point is it determined that despite the fact that it is possible to save an animal’s life, it is in the best interest of the animal not to do so? As Professor Fitzpatrick has stated:
“The bottom line now is that anything is possible, if you have a blood and nerve supply. That means that we now have a line in the sand: not what is ‘possible’ but what is ‘right.’ In the past it was the case of if it wasn’t possible, you’d move to euthanasia.”
And it’s not a question that can just be dismissed. Fitzpatrick argues that we owe it attention as the flipside to having received so many benefits built on the suffering and death caused by testing on animals. Attempts to address the issue generally hinge upon ideas of the quality of life of the animal post-procedure. And with animals unable to clearly indicate their wishes, it’s up to their human caretakers to make the best decision for them, something that can be exceedingly difficult as possibilities expand and given the nature of our attachment to our pets.
Now, if you’ll excuse me, I have to see if I can convince my rats to stop procrastinating and complete their living will documents. Thoughts on this topic? Discuss in the 3D Printing & Veterinary Ethics forum over at 3DPB.com.
You May Also Like
3D Printing News Briefs, September 12, 2020: DSM, MakerOS, Evolve Additive Solutions, & Print Parts Inc.
3D Printing News Briefs runs the gamut today from materials and software to business. First, DSM is announcing a new food-safe 3D printing material, and MakerOS has a new software...
Thanks to New Round, Xometry Raised $193M Total in Funding Since 2013
Maryland-based Xometry, a custom on-demand manufacturing marketplace which recently launched a video interview series and announced a partnership with ExOne to offer metal binder jetting services, has more exciting news to...
3D Printing News Briefs, September 5, 2020
In today’s 3D Printing News Briefs, the former CEO of Carbon has joined the faculty of a prestigious university. Moving on, a 3D printing whiz and Tel Aviv professor has...
3D Printing News Briefs, August 30, 2020: Roboze, BCN3D & CREA3D, 3D Systems, ASTM International
We’re covering 3D printing business stories in today’s 3D Printing News Briefs, including investments, partnerships, industry executives, and annual reports. Federico Faggin, who invented the microprocessor, is investing in Roboze,...
View our broad assortment of in house and third party products.